Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xian Pan

Showing results (11-20 of 294) with videos related to

Pageof 30
Sort By:
Peptides|October 8, 2021
Peptides Editorial: Opioid addiction: A 2021 updateRichard J Bodnar, Ying-Xian Pan
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 5, 2016
Transcriptional Regulation of CYP2D6 ExpressionXian Pan, Miaoran Ning, Hyunyoung Jeong
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 2015
GW4064, an agonist of farnesoid X receptor, represses CYP3A4 expression in human hepatocytes by inducing small heterodimer partner expressionShu Zhang, Xian Pan, Hyunyoung Jeong
Neuron|February 15, 2011
Mix and match: heterodimers and opioid toleranceGavril W Pasternak, Ying-Xian Pan
Bioanalysis|November 19, 2010
Human microdosing for the prediction of patient responsePaul T Henderson, Chong-Xian Pan
Pharmacological Reviews|October 1, 2013
Mu opioids and their receptors: evolution of a conceptGavril W Pasternak, Ying-Xian Pan
Future Oncology (London, England)|December 13, 2006
Implications of cancer stem cells in the treatment of cancerChong-Xian Pan, Wei Zhu, Liang Cheng
BMC Molecular Biology|November 15, 2006
Characterizing exons 11 and 1 promoters of the mu opioid receptor (Oprm) gene in transgenic miceJin Xu, Mingming Xu, Ying-Xian Pan
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 2015
Farnesoid X Receptor Agonist Represses Cytochrome P450 2D6 Expression by Upregulating Small Heterodimer PartnerXian Pan, Yoon-Kwang Lee, Hyunyoung Jeong
International Journal of Molecular Sciences|April 30, 2021
Endogenous Opioid Peptides and Alternatively Spliced Mu Opioid Receptor Seven Transmembrane Carboxyl-Terminal VariantsAnna Abrimian, Tamar Kraft, Ying-Xian Pan
Pageof 30

Showing results (11-20 of 294) with videos related to

Sort By:
Pageof 30
Peptides|October 8, 2021
Peptides Editorial: Opioid addiction: A 2021 updateRichard J Bodnar, Ying-Xian Pan
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 5, 2016
Transcriptional Regulation of CYP2D6 ExpressionXian Pan, Miaoran Ning, Hyunyoung Jeong
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 2015
GW4064, an agonist of farnesoid X receptor, represses CYP3A4 expression in human hepatocytes by inducing small heterodimer partner expressionShu Zhang, Xian Pan, Hyunyoung Jeong
Neuron|February 15, 2011
Mix and match: heterodimers and opioid toleranceGavril W Pasternak, Ying-Xian Pan
Bioanalysis|November 19, 2010
Human microdosing for the prediction of patient responsePaul T Henderson, Chong-Xian Pan
Pharmacological Reviews|October 1, 2013
Mu opioids and their receptors: evolution of a conceptGavril W Pasternak, Ying-Xian Pan
Future Oncology (London, England)|December 13, 2006
Implications of cancer stem cells in the treatment of cancerChong-Xian Pan, Wei Zhu, Liang Cheng
BMC Molecular Biology|November 15, 2006
Characterizing exons 11 and 1 promoters of the mu opioid receptor (Oprm) gene in transgenic miceJin Xu, Mingming Xu, Ying-Xian Pan
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 2015
Farnesoid X Receptor Agonist Represses Cytochrome P450 2D6 Expression by Upregulating Small Heterodimer PartnerXian Pan, Yoon-Kwang Lee, Hyunyoung Jeong
International Journal of Molecular Sciences|April 30, 2021
Endogenous Opioid Peptides and Alternatively Spliced Mu Opioid Receptor Seven Transmembrane Carboxyl-Terminal VariantsAnna Abrimian, Tamar Kraft, Ying-Xian Pan
Pageof 30